Navigation Links
IV Aspirin Drip Appears to Be Safe, Effective for Migraine

MONDAY, Sept. 20 (HealthDay News) -- The intravenous administration of aspirin appears to be a safe and effective way to treat hospitalized patients suffering from either severe headaches or migraines, new research indicates.

Study author Dr. Peter J. Goadsby, of the Headache Group in the department of neurology at the University of California, San Francisco, described his team's findings in the Sept. 21 issue of Neurology.

"Intravenous aspirin is not readily available in the United States, and only on a 'named patient' basis in the United Kingdom," Goadsby noted in a news release from the American Academy of Neurology. The 'named patient' program is for those who have exhausted approved treatment options and do not qualify for a clinical trial.

Pointing out that use of intravenous (IV) aspirin is not uncommon in other parts of continental Europe, Goadsby added that his team's results "show it could be a cost-effective, safe and easy-to-use treatment for people hospitalized for headache or migraine."

To explore the IV aspirin treatment option, the study authors focused on 168 patients (including 117 women) between the ages of 18 and 75 who had been hospitalized for severe headaches or migraines. All were given 1 gram of aspirin via a drip, for an average of five doses.

Most of the patients had been diagnosed with a migraine, and almost all were also diagnosed with a "chronic daily headache," meaning that they had suffered from a headache for at least 15 days out of each of the prior three months.

All of the patients knew they were being treated with aspirin. And each study participant kept a pain diary during the process, rating pain on a 10-point scale ranging from mild to moderate to severe.

The researchers found that in more than 25 percent of the treatments, the IV aspirin caused pain to drop down a full category, namely from severe to moderate, moderate to mild, or mild to no headache.

About 40 percent of treatments had a "moderate effect" on participants' pain levels, the findings showed.

Side effects from the treatment included heartburn, nausea, vomiting, bleeding, worsening of asthma, kidney impairment and rash.

"Our findings warrant more research into the use of IV aspirin for severe headache or migraine," Goadsby stated in the news release.

Although Goadsby noted that prior research had similarly illustrated the apparent benefits of IV aspirin by comparing pain levels against a second pool of patients who did not get the treatment, Dr. Carl Stafstrom, a professor of neurology and pediatrics at the University of Wisconsin-Madison, pointed out that the current effort did not do so.

"And certainly I would want to see this approach tested with such a 'control group' to make sure that the treatment is truly safe as well as effective," Stafstrom cautioned.

"But it's an encouraging response," he added. "And there's certainly a need for new and improved treatment modalities for acute headaches among hospitalized patients. So I would say that any new treatment is welcome. But this needs more exploration."

More information

For more on migraine and headache treatment, visit the American Academy of Family Physicians.

-- Alan Mozes

SOURCES: American Academy of Neurology, news release, Sept. 14, 2010; Carl Stafstrom, M.D., Ph.D., professor, neurology and pediatrics, University of Wisconsin-Madison

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Aspirin May Boost Breast Cancer Survival
2. Cardiologists Comment on Aspirin Versus Resveratrol
3. Aspirin Alone Works Best to Prevent Clots a Year After Stenting
4. Aspirin May Increase Risk of Crohns Disease
5. Experts Advise At-Risk Diabetics to Begin Daily Aspirin Later
6. Aspirin recommendations changed for many younger diabetic patients
7. Can aspirin prolong a healthy life?
8. Low-Dose Aspirin May Reduce Colon Cancer Risk
9. Protein Appears Key to Intestinal Balance
10. How health care is paid for appears to impact outcome
11. Hospitalization Appears to Help Personality Disorder Patients
Post Your Comments:
Related Image:
IV Aspirin Drip Appears to Be Safe, Effective for Migraine
(Date:11/24/2015)... ... 24, 2015 , ... With Thanksgiving right around the corner, holiday travel season ... protect your family and vehicle. , According to the National Highway Traffic Safety Administration, ... is sharing the following safety tips from the NHTSA: , ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... it has been designated an Aetna Institute of Quality® Bariatric Surgery Facility for ... the quality and cost of health care services available to its members to ...
(Date:11/24/2015)... M.D. (PRWEB) , ... November 24, 2015 , ... ... new award for its exceptional customer service: the TrustDale certification. The award recognizes ... The Baltimore stone honing , tile and grout, and hard surface restoration ...
(Date:11/24/2015)... ... , ... Autism Speaks, the world’s leading autism science and advocacy organization, will ... generosity of people around the world. On December 1, supporters can make an online ... share the personal stories behind those gifts. , Just as Black Friday and ...
(Date:11/24/2015)... ... ... All her life, Don Peck’s mother wondered if she was a descendant of Samuel Fuller, ... After a 25-year search for information, Don and his aunt discovered that she was not, ... Turns out, it was Don’s father who was descended from not one, but four passengers ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , Nov. 24, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York.  The public is welcome to ... the Array BioPharma website.Event:Piper Jaffray Annual Healthcare ConferencePresenter:  ... December 2, 2015Time:1:30 p.m. Eastern Time Webcast: ...
(Date:11/24/2015)... and VANCOUVER, Nov. 24, 2015 /PRNewswire/ - ESSA ... EPIX ) announced today that the first patient ... of EPI-506 as a treatment for metastatic castration-resistant prostate ... and Canada.  --> the ... In the Phase 1/2 clinical trial, ESSA intends ...
(Date:11/24/2015)... COMMACK, New York , 24. November ... Hersteller des Avery Breathing Pacemaker Systems, ist ... Ph.D., als Clinical Consultant bekannt geben zu ... -->   --> ... Stockholm (Schweden). Von 1984-1986 ...
Breaking Medicine Technology: